Aprea Therapeutics, Inc. (APRE)
0.80
-0.04
(-4.60%)
USD |
NASDAQ |
Aug 31, 16:00
0.8233
+0.02
(+2.91%)
After-Hours: 06:32
Aprea Therapeutics Cash from Investing (Quarterly) : -0.0152M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0152M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.0004M |
| September 30, 2024 | -0.0003M |
| June 30, 2024 | -0.0073M |
| March 31, 2024 | -0.008M |
| December 31, 2023 | -0.0086M |
| September 30, 2023 | -0.0841M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.0175M |
| September 30, 2020 | 0.0002M |
| June 30, 2020 | 0.002M |
| March 31, 2020 | -0.0122M |
| December 31, 2019 | -0.0143M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Zymeworks, Inc. | 16.67M |
| Rhythm Pharmaceuticals, Inc. | 14.01M |
| Onconetix, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.206M |
| Cash from Financing (Quarterly) | -2.334M |
| Free Cash Flow | -12.31M |
| Free Cash Flow Per Share (Quarterly) | -0.0602 |
| Free Cash Flow to Equity (Quarterly) | -3.221M |
| Free Cash Flow to Firm (Quarterly) | -3.221M |
| Free Cash Flow Yield | -74.86% |